Industries

Lawyers for Pharmaceutical and Life Sciences Companies in Mexico

KNR Abogados

In pharmaceuticals, legal risk lies in structure and authorizations: who holds the marketing authorization (registro sanitario), who imports, which license or notice each establishment has and who its responsable sanitario is. Products with narcotic drugs or psychotropic substances add their own permits and controls, and the law limits who may import them. Each piece is reviewed before you operate or invest.

What does COFEPRIS regulate in a pharmaceutical company?

Sanitary control over the processing, import and export of medicines falls exclusively to the Ministry of Health (Secretaría de Salud), which exercises it through COFEPRIS, under articles 17 Bis and 194 of the General Health Law (Ley General de Salud, LGS). Every establishment in the chain, from the manufacturing plant to the warehouse and the pharmacy, must hold the health license (licencia sanitaria) or notice of operation (aviso de funcionamiento) that matches its activity, and every medicine must have its marketing authorization. That combination of establishment, product and operating authorizations is what gets reviewed before entering the market and before investing.

Automated filling line for medicine bottles in a pharmaceutical plant, in black and white

Where are the sector’s legal challenges concentrated?

  • Structure and ownership: the importer must be domiciled in Mexico (article 285 of the LGS), and the marketing authorization holder must have a manufacturing plant or laboratory license or, if it is a foreign manufacturer, the permit from its own country, under article 168 of the Health Supplies Regulation (Reglamento de Insumos para la Salud, RIS).
  • Licenses and responsable sanitario: a license or notice under article 258, and a responsable sanitario (the licensed professional responsible for the establishment’s sanitary compliance) with the profile set out in article 260.
  • Import: a prior marketing authorization, the holder’s consent when the importer is someone else, and sanitary permits (article 131 of the RIS).
  • Controlled products: article 290 of the LGS defines which establishments may import narcotic drugs (estupefacientes) and psychotropic substances (psicotrópicos), in addition to the special cases the Ministry of Health authorizes.
  • Inspections and measures: the authority can impose safety measures, such as seizure, and sanctions, such as closure (articles 404 and 417); we cover this in our administrative law practice.
  • Regulatory changes: the LGS was amended on January 15, 2026 and the RIS on April 24, 2026, including the marketing authorization regime.

What should you review before operating or buying?

If you are entering the market, start with which authorizations you need from COFEPRIS, license or notice and responsable sanitario and, if the product is controlled, the import framework. If you are buying a company in the sector, a regulatory review as part of legal due diligence lets you confirm licenses, marketing authorizations and permits before closing. For the corporate structure, see company formation for foreign investors, and for compliance programs, our compliance practice.

Updated November 2026.

This content is informational and does not constitute legal advice. Every case requires individual analysis.

What the sector faces
01

Structure and marketing authorization holder

The importer must be domiciled in Mexico, and the marketing authorization holder must meet the requirements of the regulation. A structure that does not separate those roles forces filings to be redone.

02

Licenses, notices and responsable sanitario

Each establishment needs a license or notice depending on its activity, and a responsable sanitario with the profile the law requires. A mistake in category or profile exposes you to sanctions.

03

Importing medicines

Importing for commercial purposes requires a prior marketing authorization, the holder's consent if the importer is someone else, sanitary permits and enrollment in the applicable importers' registry.

04

Narcotic drugs and psychotropic substances

The law limits who may import them and requires control books, import permits and, for certain establishments, notices of estimates. Designing the structure is a legal decision that comes before the investment.

05

Inspections and safety measures

The authority can carry out inspection visits, seize products, suspend activities or order closure. Keeping files in order and having a protocol for inspection visits reduces your exposure.

06

Due diligence and regulatory change

When investing or acquiring, it pays to review licenses, marketing authorizations, permits and responsables sanitarios, and to keep up with the reforms that adjust the sanitary framework.

Practices involved

The practices this sector usually needs

Relevant experience

We assist local companies and multinationals in the pharmaceutical, biotechnology and medical device sectors, among others in the health field. We cover everything from regulatory prevention, with internal sanitary audits and risk matrices, to managing marketing authorizations, licenses, notices and import permits before COFEPRIS, and defense in inspections, precautionary measures and administrative litigation.

Frequently asked questions

Your questions, answered

What changed in 2026 in the regulation of medicines in Mexico?

Under the amended text of the General Health Law (decree published in the Official Gazette of the Federation, DOF, on January 15, 2026), only the Ministry of Health may carry out the good manufacturing practices verification that precedes the marketing authorization (article 222); that decree also amended article 376, which governs the term and extension of the marketing authorization, and the lists of narcotic drugs and psychotropic substances (articles 234 and 245). The Health Supplies Regulation was amended on April 24, 2026 with respect to the marketing authorization rules; matters already in process follow the provisions in force when they were filed.

Can a foreign company hold a marketing authorization (registro sanitario)?

The Health Supplies Regulation requires a manufacturing plant or laboratory license to be a holder and, for foreign manufacturers, the manufacturing permit from their country (article 168); in addition, for allopathic medicines manufactured abroad, it requires evidence of a legal representative domiciled in Mexico (article 170, section III). Each structure must be reviewed case by case.

Does sanitary regulation also cover medical devices?

Yes. The General Health Law subjects medical devices to sanitary control (article 194, section II) and requires a marketing authorization for them, except for low-risk devices that the authority determines do not require one (article 376). This page focuses on medicines; the requirements for each device are reviewed separately.

What happens if the sanitary authority conducts an inspection visit?

The General Health Law allows safety measures with immediate effect, such as seizure of products or suspension of activities, and sanctions such as a fine or closure (articles 404 and 417). Keeping the file for each authorization and a protocol for inspection visits helps demonstrate compliance; the strategy is defined with legal advice.

Does your company operate in this sector?

Tell us what is happening and we will tell you whether it is a matter we can take on, what it would involve, and how the scope is defined.

A lawyer will review your matter and confirm the next step within 24 business hours.